US-based Catalent is expanding its clinical supply facility in Singapore. A $2.2 million investment will provide an additional 31,000 square feet, representing a 20 per cent increase in floor space. It will allow for the addition of 35 ultra-low temperature freezers.

Along with the increased capacity, the site will grow its specialised secondary packaging capability for ULT products, allowing it to support more extensive packaging campaigns. The site will be able to handle more biopharmaceuticals and advanced products such as mRNA vaccines, as well as cell and gene therapies.

The factory performs clinical supply management, comparator sourcing, packaging, storage, global distribution and clinical returns and destruction.